These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1716311)

  • 1. Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition.
    Massey WA; Cohan VL; MacGlashan DW; Gittlen SW; Kagey-Sobotka A; Lichtenstein LM; Warner JA
    J Pharmacol Exp Ther; 1991 Sep; 258(3):824-9. PubMed ID: 1716311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
    Warner JA; MacGlashan DW
    J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells.
    Kimata M; Shichijo M; Miura T; Serizawa I; Inagaki N; Nagai H
    Biochem Biophys Res Commun; 1999 Apr; 257(3):895-900. PubMed ID: 10208881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
    White JR; Zembryki D; Hanna N; Mong S
    Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
    Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
    Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
    Bergstrand H; Lundquist B; Karabelas K; Michelsen P
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of calmodulin and protein kinase C in histamine secretion from mast cells.
    Chakravarty N
    Agents Actions; 1992 Jul; 36(3-4):183-91. PubMed ID: 1382371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin.
    Cohan VL; MacGlashan DW; Warner JA; Lichtenstein LM; Proud D
    Biochem Pharmacol; 1991 Jan; 41(2):293-300. PubMed ID: 1703413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a potent selective protein kinase C inhibitor on histamine release from rat mast cells.
    Takei M; Endo K
    J Pharm Sci; 1993 Feb; 82(2):209-10. PubMed ID: 7680376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of second messenger systems in mast cell activation.
    White JR; Zembryki D
    Agents Actions; 1989 Jun; 27(3-4):410-3. PubMed ID: 2477999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.
    Amon U; von Stebut E; Subramanian N; Wolff HH
    Pharmacology; 1993 Sep; 47(3):200-8. PubMed ID: 7692457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP modulates anti-IgE-induced release of histamine from human lung mast cells.
    Schulman ES; Glaum MC; Post T; Wang Y; Raible DG; Mohanty J; Butterfield JH; Pelleg A
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):530-7. PubMed ID: 10030852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tyrosine kinases in IgE-mediated signal transduction in human lung mast cells and basophils.
    Lavens SE; Peachell PT; Warner JA
    Am J Respir Cell Mol Biol; 1992 Dec; 7(6):637-44. PubMed ID: 1280450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of N-formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-induced arachidonic acid release in guinea pig alveolar macrophages: involvement of a GTP-binding protein and role of protein kinase A and protein kinase C.
    Kadiri C; Cherqui G; Masliah J; Rybkine T; Etienne J; Béréziat G
    Mol Pharmacol; 1990 Sep; 38(3):418-25. PubMed ID: 2119477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
    de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
    J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.